PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons
E-Collection

Related Articles
Community-Nominated Targets
July 2015
Drug Discovery: Solving the Structure of an Anti-hypertension Drug Target
July 2015
Retrospective: 7,000 Structures Closer to Understanding Biology
July 2015
Design and Evolution: Unveiling Translocator Proteins
June 2015
Signaling with DivL
May 2015
Signaling: A Platform for Opposing Functions
May 2015
Signaling: Securing Lipid-Protein Partnership
May 2015
Dynamic DnaK
March 2015
Iron-Sulfur Cluster Biosynthesis
December 2014
Mitochondrion: Flipping for UCP2
December 2014
Mitochondrion: Setting a New TRAP1
December 2014
Power in Numbers
August 2014
Quorum Sensing: A Groovy New Component
August 2014
Quorum Sensing: E. coli Gets Involved
August 2014
iTRAQing the Ubiquitinome
July 2014
Microbiome: The Dynamics of Infection
September 2013
Protein-Nucleic Acid Interaction: A Modified SAM to Modify tRNA
July 2013
Protein-Nucleic Acid Interaction: Versatile Glutamate
July 2013
PDZ Domains
April 2013
Alpha-Catenin Connections
March 2013
Cell-Cell Interaction: A FERM Connection
March 2013
Cell-Cell Interaction: Magic Structure from Microcrystals
March 2013
Cell-Cell Interaction: Modulating Self Recognition Affinity
March 2013
Bacterial Hemophores
January 2013
Archaeal Lipids
December 2012
Membrane Proteome: Capturing Multiple Conformations
December 2012
Lethal Tendencies
October 2012
Symmetry from Asymmetry
October 2012
A signal sensing switch
September 2012
Regulatory insights
September 2012
AlkB Homologs
August 2012
Budding ensemble
August 2012
Targeting Enzyme Function with Structural Genomics
July 2012
The machines behind the spindle assembly checkpoint
June 2012
Chaperone interactions
April 2012
Pilus Assembly Protein TadZ
April 2012
Revealing the Nuclear Pore Complex
March 2012
Topping off the proteasome
March 2012
Twist to open
March 2012
Disordered Proteins
February 2012
Analyzing an allergen
January 2012
Making Lipopolysaccharide
January 2012
Pulling on loose ends
January 2012
Terminal activation
December 2011
The Perils of Protein Secretion
November 2011
Bacterial Armor
October 2011
TLR4 regulation: heads or tails?
October 2011
Ribose production on demand
September 2011
Moving some metal
August 2011
Looking for lipids
July 2011
Ribofuranosyl Binding Protein
June 2011
A molecular switch for neuronal growth
May 2011
Cell wall recycler
May 2011
Added benefits
April 2011
NMR challenges current protein hydration dogma
March 2011
Nitrile Reductase QueF
March 2011
Tip formin
March 2011
Inhibiting factor
February 2011
PASK staying active
February 2011
Tryptophanyl-tRNA Synthetase
February 2011
Regulating nitrogen assimilation
January 2011
Subtle shifts
January 2011
Nitrobindin
December 2010
Function following form
October 2010
tRNA Isopentenyltransferase MiaA
August 2010
Importance of extension for integrin
June 2010
Phytochrome
April 2010
Alg13 Subunit of N-Acetylglucosamine Transferase
February 2010
Hemolysin BL
January 2010
Secretagogin
December 2009
Two-component signaling
December 2009
Network coverage
November 2009
Pseudouridine Synthase TruA
November 2009
Unusual cell division
October 2009
Toxin-antitoxin VapBC-5
September 2009
Salicylic Acid Binding Protein 2
August 2009
Proofreading RNA
July 2009
Ykul structure solves bacterial signaling puzzle
July 2009
Hda and DNA Replication
June 2009
Controlling p53
May 2009
Mitotic checkpoint control
May 2009
Ribonuclease and Ribonuclease Inhibitor
April 2009
The elusive helicase
April 2009
Aquaglyceroporin
March 2009
High-energy storage system
February 2009
A new class of bacterial E3 ubiquitination enzymes
January 2009
Poly(A) RNA recognition
January 2009
Activating BAX
December 2008
Scavenger Decapping Enzyme DcpS
November 2008
Bacteriophage Lambda cII Protein
October 2008
New metal-binding domain
October 2008
Blocking AmtB
September 2008
T-Rex
September 2008
Aspartate Dehydrogenase
August 2008
RNase T
July 2008
Chronophin
May 2008

Research Themes Cell biology

Retrospective: 7,000 Structures Closer to Understanding Biology

SBKB [doi:10.1038/sbkb.2015.23]
Featured Article - July 2015
Short description: As PSI:Biology comes to a close this month, we take a look back at all the biological advances made by the PSI Network.


The active site of NDM-1, in which many of the residues responsible for substrate binding and catalysis are on flexible loops. Image courtesy of Jim Sacchettini.

The Protein Structure Initiative has solved 6,900 protein structures in 15 years as a result of newly developed high-throughput (HTP) technologies. As the PSI comes to a close this month, we highlight some of the biological advances made by the PSI:Biology Network. For a broader review of PSI results, we invite you to revisit the ∼500 research and technical reviews written by Nature Publishing Group, and the Featured Systems illustrated by David Goodsell on the SBKB's new homepage beginning in July 2015.

The Protein Structure Initiative was created in 2000 to extend the results of the Human Genome Project by determining the three-dimensional structures of key proteins in an analogous high-throughput (HTP) manner. The pilot phase (2000–2005) initiated the creation of pipelines for protein production and structure determination to quickly isolate thousands of constructs and obtain more than 1,000 structures as a proof of concept. During PSI-2 (2005–2010), the dials were turned up as the PSI aimed to cover more structural space, adding 5,000 more structures to the PDB consisting of key proteins, domains and novel representative structures. During the third and final phase of the PSI:Biology program (2010–2015), HTP efforts were directed towards more difficult biological and biomedical problems, such as membrane proteins, complexes and networks.

The PSI:Biology HTP centers selected targets from a wide variety of biological subject areas, from basic cell biology to infectious diseases to drug discovery. For example, researchers at the PSI JCSG characterized many novel proteins and domains of unknown function from human gut flora to help determine their role in maintaining human health 1, 2, 3 . They also used their HTP pipelines to study viral-host interactions. After ten years and thousands of constructs, JCSG researchers captured the structure of HIV-1 envelope proteins in complex with antibodies from HIV-infected individuals 4, 5 , providing insights into the very elongated and specific interaction interface. This knowledge should be useful to direct structure-based vaccine development.

Researchers at PSI MCSG focused on proteins related to microbial pathogenesis. One example from their numerous achievements was the structure of Klebsiella pneumoniae New Delhi metalloproteinase-1 (NDM-1), an enzyme responsible for inactivating nearly all available β-lactam antibiotics 6, 7 . Through the use of X-ray crystallography and computational techniques, the PSI MCSG researchers and their biological partners at PSI MTBI were able to solve the first structure of NDM-1 and then model modes for substrate recognition and the catalytic mechanism, explaining how the active site could utilize zinc and other metal cofactors depending on reaction conditions. This study will enable the development of better NDM-1 inhibitors.

PSI NESG researchers continued covering the human cancer proteome 8, 9 , and also explored the rules of protein folding and design with community collaborator David Baker 10 . To accomplish this, hundreds of engineered sequences were modeled, and samples were then created and structurally determined. The researchers found that the sequence wasn't the sole determining factor driving folding, but the length of the sequences and loops that connect different secondary structure elements could favor a particular fold.

The PSI NYSGRC, partnering with PSI IFN, aimed to cover the secreted proteome that modulates adaptive and innate immunity, in the hopes of developing new therapeutics against chronic infections or cancer. This project faced many challenges regarding eukaryotic protein production and cocrystallization, but ultimately produced a half-dozen structures of wild-type and mutant cytokine LIGHT 11 in complex with its inhibitor, the soluble TNF decoy 3 receptor (DcR3), and its TNF modulation receptors HVEM and LT?R. These studies allowed NYSGRC investigators to determine the basis for substrate promiscuity for both LIGHT and DcR3, and will open the door for the development of new mechanistic probes.

The PSI:Biology program also set its sights on empowering the membrane protein community, since there were relatively few such structures in the PDB. Nine membrane protein centers focused on GPCRs, transporters and other representatives of the membrane proteome. The PSI GPCR Network determined 16 unique GPCR superfamily structures, many of which were cocrystallized with antagonists to facilitate further drug discovery. One particular milestone was the first structure of the human glucagon receptor 12 , determined in collaboration with the PSI JCSG. This structure offered the first look at Class B (secretin-like) GPCRs, and revealed a much wider active site than that observed in Class A receptors. In addition, the structure of the delta-opioid receptor 13 was selected as one of Science Signaling's Signaling Breakthroughs of 2014 14 . PSI NYCOMPS researchers solved over 30 structures of human membrane proteins or their bacterial orthologs to elucidate the mechanisms of key biological functions. The 2.3-MDa rabbit ryanodine receptor mediates muscle action through the release of calcium from intracellular stores to the cytosol, and had evaded structural determination for a long time due to its large size; this target was finally tackled by PSI NYCOMPS using cryo-electron microscopy 15 .

The 13 HTP-enabled Biology Partners benefited from the expertise of the HTP centers, as they were able to obtain hundreds of protein samples and use the centers' structure determination pipelines to advance research on T-cell biology, chemokines, stem cells, cell-cell and cell-matrix interactions, tight junctions, the mitochondrion, epigenetics, tuberculosis inhibitors and many more fields. Their outcomes are too numerous to report here, but can be surveyed in the 200+ research articles published by the Partners. We hope that these, and all PSI biological advances, will enable research for years to come.

References

  1. D. Das et al. Structure and function of the DUF2233 domain in bacteria and in the human mannose 6-phosphate uncovering enzyme.
    J Biol Chem. 288, 16789-16799 (2013). doi:10.1074/jbc.M112.434977

  2. N. M. Fleischman et al. Molecular characterization of novel pyridoxal-5′-phosphate-dependent enzymes from the human microbiome.
    Protein Sci. 23, 1060-1076 (2014). doi:10.1002/pro.2493

  3. P. Natarajan et al. Structure and sequence analyses of Bacteroides proteins BVU_4064 and BF1687 reveal presence of two novel predominantly-beta domains, predicted to be involved in lipid and cell surface interactions.
    BMC Bioinformatics. 16, 7 (2015). doi:10.1186/s12859-014-0434-7

  4. J. P. Julien et al. Crystal structure of a soluble cleaved HIV-1 envelope trimer.
    Science. 342, 1477-1483 (2013). doi:10.1126/science.1245625

  5. L. Kong et al. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.
    Nat Struct Mol Biol. 20, 796-803 (2013). doi:10.1038/nsmb.2594

  6. Y. Kim et al. Structure of apo- and monometalated forms of NDM-1-a highly potent carbapenem-hydrolyzing metallo-beta-lactamase.
    PLoS One. 6, e24621 (2011). doi:10.1371/journal.pone.0024621

  7. Y. Kim et al. NDM-1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism.
    FASEB J. 27, 1917-1927 (2013). doi:10.1096/fj.12-224014

  8. S. V. Pulavarti et al. Solution NMR structures of immunoglobulin-like domains 7 and 12 from obscurin-like protein 1 contribute to the structural coverage of the human cancer protein interaction network.
    J Struct Funct Genomics. 15, 209-214 (2014). doi:10.1007/s10969-014-9185-y

  9. X. Xu et al. Solution NMR structures of homeodomains from human proteins ALX4, ZHX1, and CASP8AP2 contribute to the structural coverage of the Human Cancer Protein Interaction Network.
    J Struct Funct Genomics. 15, 201-207 (2014). doi:10.1007/s10969-014-9184-z

  10. N. Koga et al. Principles for designing ideal protein structures.
    Nature. 491, 222-227 (2012). doi:10.1038/nature11600

  11. W. Liu et al. Mechanistic basis for functional promiscuity in the TNF and TNF receptor superfamilies: structure of the LIGHT:DcR3 assembly.
    Structure. 22, 1252-1262 (2014). doi:10.1016/j.str.2014.06.013

  12. F. Y. Siu et al. Structure of the human glucagon class B G-protein-coupled receptor.
    Nature. 499, 444-449 (2013). doi:10.1038/nature12393

  13. G. Fenalti et al. Molecular control of delta-opioid receptor signalling.
    Nature. 506, 191-196 (2014). doi:10.1038/nature12944

  14. J. D. Berndt & W. Wong 2014: signaling breakthroughs of the year.
    Sci Signal. 8, eg1 (2015). doi:10.1126/scisignal.aaa4696

  15. R. Zalk et al. Structure of a mammalian ryanodine receptor.
    Nature. 517, 44-49 (2015). doi:10.1038/nature13950

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health